ReadYourDNA

Aspirin

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Aspirin

What it is

Aspirin (acetylsalicylic acid) permanently blocks the COX enzymes. At low doses it mainly stops platelets from making thromboxane, so it is used to prevent heart attacks and strokes in people at high risk; at higher doses it relieves pain, fever and inflammation. It is one of the most widely used medicines in the world.

How genes come into it

No single gene has strong evidence for aspirin. Many studies on this page list CYP2C19 because they followed people taking aspirin together with clopidogrel, whose activation depends on that gene. Others have looked at platelet genes such as PEAR1, ITGA2 and TBXA2R for how strongly aspirin dampens platelets, and at HLA-DPB1*03:01 for aspirin-exacerbated asthma. There is no CPIC or DPWG guideline.

What research found

Every published finding on gene variants and Aspirin. Upload your DNA file to see which of these rows apply to you.

Rated evidence (79 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

HLA-DPB1 HLA-DPB1*03:01: Level 2B · replicated. Toxicity: Asthma. 3.

ITGA2 rs1126643: Level 3. Efficacy: Coronary Artery Disease, Coronary Disease, Myocardial Infarction. 5.

P2RY1 rs1065776: Level 3. Efficacy: Myocardial Infarction. 3.

LTC4S rs730012: Level 3. Toxicity: Urticaria. 3.

Response (34 findings)

Studies of how well it worked in people carrying a variant.

ABCB1 rs1045642: Genotype GG is associated with increased clinical benefit to aspirin in people with Stroke as compared to genotypes AA + AG.

CYP2C19 CYP2C19*1, CYP2C19*2: CYP2C19 *2 is associated with decreased response to aspirin and clopidogrel in people with Acute coronary syndrome as compared to CYP2C19 *1.

CYP2C19 CYP2C19*1, CYP2C19*2: CYP2C19 *2/*2 is associated with decreased response to aspirin and clopidogrel in people with Acute coronary syndrome as compared to CYP2C19 *1/*1 + *1/*2.

CYP2C19 CYP2C19*1, CYP2C19*2, CYP2C19*3: CYP2C19 *2 + *3 are associated with decreased response to aspirin and clopidogrel as compared to CYP2C19 *1/*1.

Other findings (1 finding)

Studies that do not fall into the groups above.

CYP2C19 rs12248560: Allele T is associated with increased response to aspirin and clopidogrel in people with Coronary Artery Disease as compared to allele C.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Advil (NSAIDs)

Aleve (NSAIDs)

Clinoril (NSAIDs)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com